Rachel Klemovitch, Assistant Editor03.27.24
Custom contract manufacturer and solutions provider, Velosity has updated its commercial excellence framework to outpace market demands and fuel sustained growth. Organizational changes were put into effect on March 18, and further positions the company to capitalize on emerging opportunities in the medical technology and pharmaceutical industries.
Greg Fischer joins the company as VP of Sales, Medical. He brings extensive expertise in injection molding, mold making, and contract manufacturing. Fischer previously served at National Mold as the Corporate VP of Sales and Marketing and at iMark Molding as the VP of Sales.
At Velosity Fischer will drive outreach efforts with an emphasis on partnering with industry leaders in medtech, pharmaceutical, and life sciences segments.
Darren Bjork has been promoted to Senior Vice President, Commerical and will lead medical sales and marketing initiatives with a focus on high-growth clinical areas in the medical space.
CEO Dave Hemink commented: “These enhancements underscore our commitment to staying ahead of market trends and delivering exceptional value to our customers. We are confident that the collective expertise of our leadership team, combined with our innovative solutions, will position Velosity for continued success in both the medical technology and pharmaceutical sectors."
Greg Fischer joins the company as VP of Sales, Medical. He brings extensive expertise in injection molding, mold making, and contract manufacturing. Fischer previously served at National Mold as the Corporate VP of Sales and Marketing and at iMark Molding as the VP of Sales.
At Velosity Fischer will drive outreach efforts with an emphasis on partnering with industry leaders in medtech, pharmaceutical, and life sciences segments.
Darren Bjork has been promoted to Senior Vice President, Commerical and will lead medical sales and marketing initiatives with a focus on high-growth clinical areas in the medical space.
CEO Dave Hemink commented: “These enhancements underscore our commitment to staying ahead of market trends and delivering exceptional value to our customers. We are confident that the collective expertise of our leadership team, combined with our innovative solutions, will position Velosity for continued success in both the medical technology and pharmaceutical sectors."